생체 흡수 스텐트 시장 규모, 점유율, 성장 분석, 제품 유형별, 흡수율별, 용도별, 지역별 - 산업 예측(2025-2032년)
Bioabsorbable Stents Market Size, Share, and Growth Analysis, By Product Type, By Absorption Rate, By Application, By Region - Industry Forecast 2025-2032
상품코드:1670157
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 194 Pages
라이선스 & 가격 (부가세 별도)
한글목차
생체 흡수성 스텐트 시장 규모는 2023년 25억 6,000만 달러로 평가되었습니다. 2024년 27억 9,000만 달러에서 2032년에는 55억 1,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 8.9%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
세계 생체 흡수성 스텐트 시장은 고령화와 심혈관 질환 유병률 증가로 인해 크게 성장할 것으로 예상됩니다. 관상동맥 질환 증가는 경피적 관상동맥 성형술(PCI) 시술 증가로 이어져 환자와 의료진 모두 생체 흡수성 스텐트의 채택을 확대하고 있습니다. 기술 발전과 최소 침습적 치료로의 전환은 시장 확대를 더욱 촉진하고 있습니다. 기술 혁신을 촉진하는 개발 이니셔티브와 유리한 규제는 생체 흡수성 스텐트 개발을 촉진하고 있습니다. 그러나 높은 시술 비용과 스텐트 시술에 따른 잠재적 위험과 같은 문제는 성장을 저해하는 요인으로 작용할 수 있습니다. 전반적으로 인구 통계학적 변화, 기술 발전, 정부 지원책이 시장의 미래 궤도를 형성하는 데 중요한 역할을 할 것으로 보입니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
규제 상황
생체 흡수 스텐트 시장 규모 : 제품 유형별
시장 개요
폴리머 기반 생체 흡수 스텐트
메탈 기반 생체 흡수 스텐트
생체 흡수 스텐트 시장 규모 : 흡수율별
시장 개요
저속 흡수 스텐트
고속 흡수 스텐트
생체 흡수 스텐트 시장 규모 : 폴리머 기반 생체 흡수 스텐트별
시장 개요
폴리(젖산-글리콜산) 스텐트
폴리 글리콜산스텐트
폴리(L-젖산) 스텐트
기타 생분해성 폴리머 스텐트
생체 흡수 스텐트 시장 규모 : 메탈 기반 생체 흡수 스텐트별
시장 개요
마그네슘 기반 스텐트
철 기반 스텐트
아연 기반 스텐트
기타 메탈 기반 생체 흡수 스텐트
생체 흡수 스텐트 시장 규모 : 용도별
시장 개요
관상 동맥 질환
말초 동맥 질환
생체 흡수 스텐트 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022-2024년)
주요 기업 개요
Boston Scientific Corporation(USA)
Arterius Limited(UK)
Kyoto Medical Planning Co., Ltd.(Japan)
Terumo Corporation(Japan)
Elixir Medical Corporation(USA)
Abbott Laboratories Inc.(USA)
Amaranth Medical(USA)
Biotronik(Germany)
Meril Life Sciences Pvt. Ltd.(India)
Reva Medical(USA)
Svelte Medical Systems(USA)
Lepu Medical Technology Co., Ltd.(China)
Medtronic plc(Ireland)
B. Braun Melsungen AG(Germany)
MicroPort Scientific Corporation(China)
Cardionovum GmbH(Germany)
Biotronik SE & Co. KG(Germany)
ICON Interventional Systems(USA)
Arterial Remodeling Technologies(France)
Elixir Medical Corporation(USA)
결론과 제안
LSH
영문 목차
영문목차
Bioabsorbable Stents Market size was valued at USD 2.56 billion in 2023 and is poised to grow from USD 2.79 billion in 2024 to USD 5.51 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).
The global bioabsorbable stents market is poised for significant growth driven by an aging population and escalating cardiovascular disease prevalence. The rise in coronary artery disease has led to an uptick in percutaneous coronary intervention (PCI) procedures, amplifying the adoption of bioabsorbable stents by both patients and healthcare providers. Technological advancements and a shift towards minimally invasive treatments further boost market expansion. Government initiatives promoting innovation and favorable regulations enhance the development of bioabsorbable stents. However, challenges such as the high cost of procedures and potential risks associated with these stents could impede growth. Overall, demographic shifts, technological progress, and supportive government measures will play crucial roles in shaping the market's future trajectory.
Top-down and bottom-up approaches were used to estimate and validate the size of the Bioabsorbable Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Bioabsorbable Stents Market Segments Analysis
Global Bioabsorbable Stents Market is segmented by Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application and region. Based on Product Type, the market is segmented into Polymer-Based Bioabsorbable Stents and Metal-Based Bioabsorbable Stents. Based on Absorption Rate, the market is segmented into Slow-Absorption Stents and Fast-Absorption Stents. Based on Polymer-Based Bioabsorbable Stents, the market is segmented into PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly (L-Lactic Acid)) Stents and Other Biodegradable Polymer Stents. Based on Metal-Based Bioabsorbable Stents, the market is segmented into Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents and Other Metal-Based Bioabsorbable Stents. Based on Application, the market is segmented into Coronary Artery Diseases and Peripheral Artery Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Bioabsorbable Stents Market
The Bioabsorbable Stents market is significantly driven by advancements in design and technology, which have accelerated the treatment of coronary artery disease with biodegradable stents. These innovative stents are crafted from biodegradable polymers that safely dissolve after fulfilling their purpose, enhancing patient outcomes. Research by the U.S. FDA has highlighted the potential of these stents to mitigate late-stage complications, such as stent thrombosis. As a result, there is an increased patient acceptance and utilization, fostering wider market adoption and positioning bioabsorbable stents as a promising solution in cardiovascular care, effectively addressing a critical healthcare need for safer and more effective treatments.
Restraints in the Bioabsorbable Stents Market
The bioabsorbable stents market faces significant challenges due to concerns surrounding the long-term efficacy and safety of these devices. Healthcare providers remain skeptical, particularly following complications linked to several first-generation models, such as late stent thrombosis and restenosis, which have cast doubts on their clinical performance. These issues have negatively impacted market confidence, leading clinicians to advocate for more extensive clinical trials and the development of improved device designs. To regain trust in bioabsorbable stent technology, it is essential to establish enhanced safety profiles and provide comprehensive long-term data demonstrating their reliability and effectiveness in patient care.
Market Trends of the Bioabsorbable Stents Market
The bioabsorbable stents market is experiencing a significant trend towards the development of innovative materials aimed at enhancing clinical outcomes. Researchers are focusing on creating advanced composite materials that provide superior biocompatibility, increased mechanical strength, and optimized degradation rates. These improvements are designed to address the limitations of existing stent materials, ultimately leading to better patient outcomes and performance. This market shift highlights a commitment to enhancing the durability and long-term efficacy of bioabsorbable stents, thereby minimizing complications and bolstering the overall efficacy of cardiac interventions. As a result, growth in this segment is expected to accelerate significantly in the coming years.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Global Bioabsorbable Stents Market Size by Product Type & CAGR (2025-2032)
Market Overview
Polymer-Based Bioabsorbable Stents
Metal-Based Bioabsorbable Stents
Global Bioabsorbable Stents Market Size by Absorption Rate & CAGR (2025-2032)
Market Overview
Slow-Absorption Stents
Fast-Absorption Stents
Global Bioabsorbable Stents Market Size by Polymer-Based Bioabsorbable Stents & CAGR (2025-2032)
Market Overview
PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents
PGA (Polyglycolic Acid) Stents
PLLA (Poly (L-Lactic Acid)) Stents
Other Biodegradable Polymer Stents
Global Bioabsorbable Stents Market Size by Metal-Based Bioabsorbable Stents & CAGR (2025-2032)
Market Overview
Magnesium-Based Stents
Iron-Based Stents
Zinc-Based Stents
Other Metal-Based Bioabsorbable Stents
Global Bioabsorbable Stents Market Size by Application & CAGR (2025-2032)
Market Overview
Coronary Artery Diseases
Peripheral Artery Diseases
Global Bioabsorbable Stents Market Size & CAGR (2025-2032)
North America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
